Schedule 13G ownership disclosure
TITAN PHARMACEUTICALS INC
Security class unavailable · CUSIP: 888314101
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.6300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-128667
- Form type
- SC 13G
- Filer
- MEAD ROBERT E
- CIK
- CIK 1040747
- Filed
- Apr 19, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership